Day 2Structural heart diseaseValvular Aortic valve

SOLACI CACI | TAVI: Evidencia para pacientes de riesgo intermedio

solaci
solaci
456
0
Dr. Oscar Méndiz
Dr. Oscar Méndiz

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress.

See the presentation by Dr. Oscar Méndiz, entitled “TAVI: Evidencia para pacientes de riesgo intermedio”.

3Oscar-MendizIntermedia

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI CACI 2017 | BRS at the crossroad: technological development to reduce complications
Next article
SOLACI CACI 2017 | Tipo II Endoleaks: Tratamiento obligatorio o un miedo infundado
solaci
solaci

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

Calcified Nodules and Their Treatment with Rotational Atherectomy

Dr. Omar Tupayachi - 0
Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Dr. Omar Tupayachi - 0
Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Dr. Andrés Rodríguez - 0
Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...